About BioAge Labs
BioAge Labs is a company based in Vallejo (United States) founded in 2015 by Eric Morgen.. BioAge Labs has raised $293.9 million across 4 funding rounds from investors including Amgen, Kaiser Permanente and AARP. The company has 64 employees as of December 31, 2024. BioAge Labs offers products and services including NLRP3 Program, APJ Program, and Discovery Platform. BioAge Labs operates in a competitive market with competitors including Helix, Benchling, NantHealth, AskBio and Adocia, among others.
- Headquarter Vallejo, United States
- Employees 64 as on 31 Dec, 2024
- Founders Eric Morgen
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Bioage Labs, Inc.
-
Annual Revenue
$00as on Dec 31, 2024
-
Net Profit
$-71.11 M-11.36as on Dec 31, 2024
-
EBITDA
$-78.03 M-61.75as on Dec 31, 2024
-
Total Equity Funding
$293.9 M (USD)
in 4 rounds
-
Latest Funding Round
$170 M (USD), Series D
Feb 13, 2024
-
Investors
Amgen
& 23 more
-
Employee Count
64
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of BioAge Labs
BioAge Labs is a publicly listed company on the NASDAQ with ticker symbol BIOA in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of BioAge Labs
BioAge Labs offers a comprehensive portfolio of products and services, including NLRP3 Program, APJ Program, and Discovery Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Targets inflammation linked to obesity and metabolic issues
Acts as exercise mimetic for weight loss in obesity
Analyzes multi-omics data for aging and disease mediators
Unlock access to complete
Unlock access to complete
Funding Insights of BioAge Labs
BioAge Labs has successfully raised a total of $293.9M across 4 strategic funding rounds. The most recent funding activity was a Series D round of $170 million completed in February 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series D — $170.0M
-
First Round
First Round
(28 Jul 2017)
- Investors Count 24
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2024 | Amount | Series D - BioAge Labs | Valuation | Sofinnova Investments | |
| Dec, 2020 | Amount | Series C - BioAge Labs | Valuation | a16z , Elad Gil | |
| Jan, 2019 | Amount | Series B - BioAge Labs | Valuation | Felicis Ventures |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in BioAge Labs
BioAge Labs has secured backing from 24 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Amgen, Kaiser Permanente and AARP. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Biotech funding, drug development support, and investment in life sciences.
|
Founded Year | Domain | Location | |
|
Private equity firm focused on life science sector
|
Founded Year | Domain | Location | |
|
Life Sciences focused VC firm investing in the US
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by BioAge Labs
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - BioAge Labs
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Bioage Labs Comparisons
Competitors of BioAge Labs
BioAge Labs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Helix, Benchling, NantHealth, AskBio and Adocia, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Genomic database for clinical research is provided.
|
|
| domain | founded_year | HQ Location |
Cloud-based bioinformatics platform is offered for biotech research.
|
|
| domain | founded_year | HQ Location |
Bioinformatics platforms are provided for cancer treatment identification.
|
|
| domain | founded_year | HQ Location |
Gene and protein therapies are developed for treating various diseases.
|
|
| domain | founded_year | HQ Location |
Therapeutics for diabetes and obesity treatment are developed.
|
|
| domain | founded_year | HQ Location |
AI-based omics data analysis solutions are provided to researchers.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Bioage Labs
Frequently Asked Questions about BioAge Labs
When was BioAge Labs founded?
BioAge Labs was founded in 2015 and raised its 1st funding round 2 years after it was founded.
Where is BioAge Labs located?
BioAge Labs is headquartered in Vallejo, United States. It is registered at Vallejo, California, United States.
Is BioAge Labs a funded company?
BioAge Labs is a funded company, having raised a total of $293.9M across 4 funding rounds to date. The company's 1st funding round was a Series B of $23M, raised on Jul 28, 2017.
How many employees does BioAge Labs have?
As of Dec 31, 2024, the latest employee count at BioAge Labs is 64.
What does BioAge Labs do?
BioAge Labs was founded in 2015 in Vallejo, United States, within the biotechnology sector. A bioinformatics platform is operated to support biomarker identification and drug discovery processes. Computational biology methods are utilized alongside AI technology to analyze genomic data for developing new therapeutic candidates. The companys efforts are centered on enhancing precision in medicine discovery through data-driven approaches.
Who are the top competitors of BioAge Labs?
BioAge Labs's top competitors include Helix, Tonix Pharma and NantHealth.
What products or services does BioAge Labs offer?
BioAge Labs offers NLRP3 Program, APJ Program, and Discovery Platform.
Is BioAge Labs publicly traded?
Yes, BioAge Labs is publicly traded on NASDAQ under the ticker symbol BIOA.
Who are BioAge Labs's investors?
BioAge Labs has 24 investors. Key investors include Amgen, Kaiser Permanente, AARP, Khosla Ventures, and Orbimed.
What is BioAge Labs's ticker symbol?
The ticker symbol of BioAge Labs is BIOA on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.